Cart
sales@molnova.com
LASV inhibitor 3.3
CAS No. 554438-52-7
LASV inhibitor 3.3( LAMP1 inhibitor 3.3 )
Catalog No. M15014 CAS No. 554438-52-7
LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 78 | Get Quote |
|
| 10MG | 129 | Get Quote |
|
| 25MG | 264 | Get Quote |
|
| 50MG | 435 | Get Quote |
|
| 100MG | 624 | Get Quote |
|
| 500MG | 1278 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLASV inhibitor 3.3
-
NoteResearch use only, not for human use.
-
Brief DescriptionLASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).
-
DescriptionLASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM), inhibits LASV GP-mediated infection and cross-links to the LASV receptor, LAMP1, in cells; does not inhibits the GP-mediated infection of LCMV, LuJo virus (LUJV) or Junin virus (JUNV), Ebola virus (EBOV) or vesicular stomatitis virus (VSV); inhibits LAMP1 binding to LASV GP, which is cholesterol-dependent and sensitive to 3.3 inhibition; LASV inhibitor 3.3 is a competitive inhibitor of cholesterol binding to LAMP1.
-
In VitroWestern Blot Analysis Cell Line:293T LAMP1 KO cells expressing LASV GP-His and 293T pX459 cells Concentration:1 and 10 μM Incubation Time:1 hour Result:Inhibited the LASV GP binds to LAMP1.
-
In Vivo——
-
SynonymsLAMP1 inhibitor 3.3
-
PathwayMicrobiology/Virology
-
TargetArenavirus
-
RecptorArenavirus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number554438-52-7
-
Formula Weight471.645
-
Molecular FormulaC30H37N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (53.01 mM)
-
SMILESC1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CNC(=O)C45CC6CC(C4)CC(C6)C5
-
Chemical NameN-(2-(4-benzhydrylpiperazin-1-yl)-2-oxoethyl)adamantane-1-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang MK, et al. PLoS Pathog. 2018 Sep 28;14(9):e1007322.
2. PCT Int. Appl. (2013), WO 2013022550 A2 20130214.
molnova catalog
related products
-
LHF-535
LHF-535 (LHF535, LHF 535) is a small-molecule viral entry inhibitor that targets the arenavirus envelope glycoprotein, exhibits potent antiviral activity against a broad array of hemorrhagic fever arenaviruses with IC50 of 0.1-0.3 nM.
-
ST-193
ST-193 (ST193) is a potent, selective, broad-spectrum arenavirus entry inhibitor with IC50 of 1.6 nM against LASV pseudotypes, targets arenavirus envelope glycoprotein.
-
GP(33-41)
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP33-41 Epitopeis a strong agonist of CD8 T cells from P14 TCR-transgenic mice.
